Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease
Clinical trial NCT04476277 · COMPLETED
Trial details
- NCT number
- NCT04476277
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-19
- Primary completion
- 2022-12-20
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.